Electromyographic (EMG) Biofeedback Training in Zone I-III Flexor Tendon Injuries

January 23, 2020 updated by: UMUT ERASLAN, Pamukkale University

The Effect of Electromyographic (EMG) Biofeedback Training on Electrical Muscle Activity and Functional Status in Zone I-III Flexor Tendon Injuries

Aim: The aim of the study was to investigate the effect of electromyographic (EMG) biofeedback training applied in addition to early passive motion protocol on electrical muscle activity (EMA) and functional status in zone I-III flexor tendon injuries.

Materials and Methods: Cases who underwent surgery for flexor tendon injuries in zone I-III were included in this prospective randomized controlled trial. Cases were randomly divided into two groups of 11 cases each by block randomization. In the first group, EMG biofeedback training was applied in addition to the early passive motion method (modified Duran protocol), while the second group was followed only by early passive motion method. The treatment program was performed by the same physiotherapist three times a week, for 12 weeks. At the postoperative 5th, 12th and 24th weeks, joint range of motion (ROM) and EMA were evaluated, and the Michigan Hand Outcome Questionnaire (MHQ) was administered to the patients. The grip strength at 12th and 24th weeks were also assessed. The Mann-Whitney U Test was used to compare the two groups.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 64 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Being olunteer,
  • No history of neurological, orthopedic, rheumatologic disease or trauma in the related extremity,
  • No history of neuropathy due to a metabolic disease (diabetes, etc.),
  • Incision of at least one of the FDS or FDP tendons,
  • At least one of the FDS or FDP tendons repaired within 2 weeks after the injury,
  • No communication problems.

Exclusion Criteria:

  • <18 years of age,
  • Pregnancy,
  • Thumb flexor tendon cuts,
  • Digital nerve injury,
  • Accompanying fracture, joint capsule injury or skin loss,
  • Crush injury,
  • Patients with pacemakers,
  • Patients with cardiac arrhythmias,
  • Epilepsy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
Experimental: EMG biofeedback group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Finger joint range of motion
Time Frame: 5th week
Finger motion was measured by goniometer.Total active motion protocol was used.
5th week
Finger joint range of motion
Time Frame: 12th week
Finger motion was measured by goniometer.Total active motion protocol was used.
12th week
Finger joint range of motion
Time Frame: 24th week
Finger motion was measured by goniometer.Total active motion protocol was used.
24th week
Electrical muscle activity
Time Frame: 5th week
Flexor muscle electrical activity was measured by EMG biofeedback device. For this purpose, surface electrodes were used.
5th week
Electrical muscle activity
Time Frame: 12th week
Flexor muscle electrical activity was measured by EMG biofeedback device. For this purpose, surface electrodes were used.
12th week
Electrical muscle activity
Time Frame: 24th week
Flexor muscle electrical activity was measured by EMG biofeedback device. For this purpose, surface electrodes were used.
24th week
Grip strength
Time Frame: 12th week
Gross and pinch strength were evaluated by hand dynamometer.
12th week
Grip strength
Time Frame: 24th week
Gross and pinch strength were evaluated by hand dynamometer.
24th week
Michigan Hand Questionnaire
Time Frame: 5th week
This questionnaire evaluates the functionality of the hand and consists of 63 questions in total. Each question is scored between 1-5 and the score of each section varies between 0-100. High total score indicates high satisfaction.
5th week
Michigan Hand Questionnaire
Time Frame: 12th week
This questionnaire evaluates the functionality of the hand and consists of 63 questions in total. Each question is scored between 1-5 and the score of each section varies between 0-100. High total score indicates high satisfaction.
12th week
Michigan Hand Questionnaire
Time Frame: 24th week
This questionnaire evaluates the functionality of the hand and consists of 63 questions in total. Each question is scored between 1-5 and the score of each section varies between 0-100. High total score indicates high satisfaction.
24th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ali Kitis, PhD, Pamukkale University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2016

Primary Completion (Actual)

December 10, 2018

Study Completion (Actual)

March 21, 2019

Study Registration Dates

First Submitted

January 15, 2020

First Submitted That Met QC Criteria

January 17, 2020

First Posted (Actual)

January 23, 2020

Study Record Updates

Last Update Posted (Actual)

January 27, 2020

Last Update Submitted That Met QC Criteria

January 23, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 60116787-020/50298

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Flexor Tendon Rupture

Clinical Trials on EMG biofeedback training

3
Subscribe